_id

690daef7ccc777a4e85d0aca

Ticker

ANGO

Name

AngioDynamics Inc

Exchange

NASDAQ

Address

14 Plaza Drive, Latham, NY, United States, 12110

Country

USA

Sector

Healthcare

Industry

Medical Instruments & Supplies

Currency

USD

Website

https://www.angiodynamics.com

Description

AngioDynamics, Inc., a medical technology company, designs, manufactures, and sells medical, surgical, and diagnostic devices for the use in treating peripheral vascular disease, and oncology and surgical settings in the United States and internationally. It offers Auryon Atherectomy system that delivers an optimized wavelength and short pulse width to remove lesions while preserving vessel wall endothelium. The company's thrombus management portfolio includes AlphaVac mechanical thrombectomy system, an emergent mechanical aspiration device that eliminates the need for perfusionist support; thrombolytic catheters that are used to deliver thrombolytic agents, which are drugs to dissolve blood clots in hemodialysis access grafts, arteries, veins, and surgical bypass grafts; and AngioVac venous drainage cannula and extracorporeal circuit for use in extracorporeal circulatory support procedures for periods of up to six hours, as well as with other manufacturers' off-the-shelf pump, filter, and reinfusion cannula facilitate venous drainage. It also offers NanoKnife IRE Ablation System, an alternative to traditional thermal ablation for the surgical ablation of soft tissue; and peripheral products, which includes angiographic catheters, diagnostic and interventional guidewires, and coaxial micro-introducer kits for use in peripheral diagnostic and interventional procedures. In addition, the company provides abscession drainage catheters for multi-purpose/general, nephrostomy, and biliary drainage; micro-access kits offer interventional physicians a smaller introducer system for minimally invasive procedures; VenaCure EVLT system that are used in endovascular laser procedures to treat superficial venous disease; and Solero Microwave Tissue Ablation System includes solero microwave generator and the solero MW applicators. AngioDynamics, Inc. was founded in 1988 and is headquartered in Latham, New York.

Last Close

13.32

Volume

460431

Current Price

13.44

Change

0.900900900900895

Last Updated

2025-11-28T12:14:38.305Z

Image

data:image/webp;base64,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

Ipo Date

2004-05-27T00:00:00.000Z

Market Cap

506758080

Next Dividend Date

-

Dividend Frequency

-

Dividend Rate

-

Dividend Yield

0

Sentiment

0.999

Sentiment Sources

1

Rating

4.6667

Target Price

18.5

Strong Buy

2

Buy

1

Hold

0

Sell

0

Strong Sell

0

Current Quarter

2025-08-31

Revenue

75711000

Cost Of Revenue

33854000

Gross Profit

41857000

Operating Expenses

52513000

Operating Income

-10656000

Interest Expense

4000

Pretax Income

-10838000

Net Income

-10903000

Eps

-0.2648030310390052

Dividends Per Share

-

Shares Outstanding

41199844

Income Tax Expense

65000

EBITDA

-4814000

Operating Margin

-14.07457304750961

Total Other Income Expense Net

-182000

Cash

38762000

Short Term Investments

-

Receivables

42643000

Inventories

62255000

Total Current Assets

156656000

Property Plant Equipment

31066000

Total Assets

265642000

Payables

31882000

Short Term Debt

-

Long Term Debt

-

Total Liabilities

86787000

Equity

178855000

Depreciation

6020000

Change In Working Capital

-16275000

Cash From Operations

-15914000

Capital Expenditures

731000

Cash From Investing

-1551000

Cash From Financing

143000

Net Change In Cash

-17131000

PE

-

PB

3.0940066534343464

ROE

-6.095999552710296

ROA

-4.104396142176313

FCF

-16645000

Fcf Percent

-0.2198491632655757

Piotroski FScore

0

Health Score

29

Deep Value Investing Score

3.5

Defensive Investing Score

7

Dividend Investing Score

1.5

Economic Moat Investing Score

4.3

Garp Investing Score

2.5

Growth Investing Score

1

Momentum Investing Score

2.5

Net Net Investing Score

2.5

Quality Investing Score

3

Value Investing Score

6

Quarters > 0 > quarter

2025-08-31

Quarters > 0 > income Statement > revenue

75711000

Quarters > 0 > income Statement > cost Of Revenue

33854000

Quarters > 0 > income Statement > gross Profit

41857000

Quarters > 0 > income Statement > operating Expenses

52513000

Quarters > 0 > income Statement > operating Income

-10656000

Quarters > 0 > income Statement > interest Expense

4000

Quarters > 0 > income Statement > pretax Income

-10838000

Quarters > 0 > income Statement > net Income

-10903000

Quarters > 0 > income Statement > eps

-0.2648030310390052

Quarters > 0 > income Statement > dividends Per Share

-

Quarters > 0 > income Statement > shares Outstanding

41174000

Quarters > 0 > income Statement > income Tax Expense

65000

Quarters > 0 > income Statement > EBITDA

-4814000

Quarters > 0 > income Statement > operating Margin

-14.07457304750961

Quarters > 0 > income Statement > total Other Income Expense Net

-182000

Quarters > 0 > balance Sheet > cash

38762000

Quarters > 0 > balance Sheet > short Term Investments

-

Quarters > 0 > balance Sheet > receivables

42643000

Quarters > 0 > balance Sheet > inventories

62255000

Quarters > 0 > balance Sheet > total Current Assets

156656000

Quarters > 0 > balance Sheet > property Plant Equipment

31066000

Quarters > 0 > balance Sheet > total Assets

265642000

Quarters > 0 > balance Sheet > payables

31882000

Quarters > 0 > balance Sheet > short Term Debt

-

Quarters > 0 > balance Sheet > long Term Debt

-

Quarters > 0 > balance Sheet > total Liabilities

86787000

Quarters > 0 > balance Sheet > equity

178855000

Quarters > 0 > cash Flow > net Income

-10903000

Quarters > 0 > cash Flow > depreciation

6020000

Quarters > 0 > cash Flow > change In Working Capital

-16275000

Quarters > 0 > cash Flow > cash From Operations

-15914000

Quarters > 0 > cash Flow > capital Expenditures

731000

Quarters > 0 > cash Flow > cash From Investing

-1551000

Quarters > 0 > cash Flow > cash From Financing

143000

Quarters > 0 > cash Flow > net Change In Cash

-17131000

Quarters > 0 > ratios > PE

-0.2648030310390052

Quarters > 0 > ratios > PB

3.0940066534343464

Quarters > 0 > ratios > ROE

-6.095999552710296

Quarters > 0 > ratios > ROA

-4.104396142176313

Quarters > 0 > ratios > FCF

-16645000

Quarters > 0 > ratios > Piotroski FScore

0

Quarters > 0 > ratios > fcf Percent

-0.2198491632655757

Quarters > 0 > health Score

29

Quarters > 1 > quarter

2025-05-31

Quarters > 1 > income Statement > revenue

80158000

Quarters > 1 > income Statement > cost Of Revenue

37940000

Quarters > 1 > income Statement > gross Profit

42218000

Quarters > 1 > income Statement > operating Expenses

48006000

Quarters > 1 > income Statement > operating Income

-5788000

Quarters > 1 > income Statement > interest Expense

-

Quarters > 1 > income Statement > pretax Income

-6110000

Quarters > 1 > income Statement > net Income

-6050000

Quarters > 1 > income Statement > eps

-0.14761858286160454

Quarters > 1 > income Statement > dividends Per Share

-

Quarters > 1 > income Statement > shares Outstanding

40984000

Quarters > 1 > income Statement > income Tax Expense

-60000

Quarters > 1 > income Statement > EBITDA

2200000

Quarters > 1 > income Statement > operating Margin

-7.2207390403952205

Quarters > 1 > income Statement > total Other Income Expense Net

-322000

Quarters > 1 > balance Sheet > cash

55893000

Quarters > 1 > balance Sheet > short Term Investments

-

Quarters > 1 > balance Sheet > receivables

43140000

Quarters > 1 > balance Sheet > inventories

62006000

Quarters > 1 > balance Sheet > total Current Assets

168324000

Quarters > 1 > balance Sheet > property Plant Equipment

32300000

Quarters > 1 > balance Sheet > total Assets

280144000

Quarters > 1 > balance Sheet > payables

33291000

Quarters > 1 > balance Sheet > short Term Debt

1840000

Quarters > 1 > balance Sheet > long Term Debt

-

Quarters > 1 > balance Sheet > total Liabilities

97174000

Quarters > 1 > balance Sheet > equity

182970000

Quarters > 1 > cash Flow > net Income

-6050000

Quarters > 1 > cash Flow > depreciation

5833000

Quarters > 1 > cash Flow > change In Working Capital

16731000

Quarters > 1 > cash Flow > cash From Operations

18811000

Quarters > 1 > cash Flow > capital Expenditures

777000

Quarters > 1 > cash Flow > cash From Investing

-2623000

Quarters > 1 > cash Flow > cash From Financing

-5770000

Quarters > 1 > cash Flow > net Change In Cash

11133000

Quarters > 1 > ratios > PE

-0.14761858286160454

Quarters > 1 > ratios > PB

3.0104659780291847

Quarters > 1 > ratios > ROE

-3.306552986828442

Quarters > 1 > ratios > ROA

-2.1596036324176136

Quarters > 1 > ratios > FCF

18034000

Quarters > 1 > ratios > Piotroski FScore

2

Quarters > 1 > ratios > fcf Percent

0.22498066319019935

Quarters > 1 > health Score

45

Quarters > 2 > quarter

2025-02-28

Quarters > 2 > income Statement > revenue

72004000

Quarters > 2 > income Statement > cost Of Revenue

33147000

Quarters > 2 > income Statement > gross Profit

38857000

Quarters > 2 > income Statement > operating Expenses

48831000

Quarters > 2 > income Statement > operating Income

-9974000

Quarters > 2 > income Statement > interest Expense

-

Quarters > 2 > income Statement > pretax Income

-4409000

Quarters > 2 > income Statement > net Income

-4407000

Quarters > 2 > income Statement > eps

-0.10787457469463686

Quarters > 2 > income Statement > dividends Per Share

-

Quarters > 2 > income Statement > shares Outstanding

40853000

Quarters > 2 > income Statement > income Tax Expense

-2000

Quarters > 2 > income Statement > EBITDA

-329000

Quarters > 2 > income Statement > operating Margin

-13.852008221765457

Quarters > 2 > income Statement > total Other Income Expense Net

5565000

Quarters > 2 > balance Sheet > cash

44760000

Quarters > 2 > balance Sheet > short Term Investments

-

Quarters > 2 > balance Sheet > receivables

48968000

Quarters > 2 > balance Sheet > inventories

63105000

Quarters > 2 > balance Sheet > total Current Assets

172273000

Quarters > 2 > balance Sheet > property Plant Equipment

32530000

Quarters > 2 > balance Sheet > total Assets

285415000

Quarters > 2 > balance Sheet > payables

30265000

Quarters > 2 > balance Sheet > short Term Debt

5000000

Quarters > 2 > balance Sheet > long Term Debt

-

Quarters > 2 > balance Sheet > total Liabilities

99545000

Quarters > 2 > balance Sheet > equity

185870000

Quarters > 2 > cash Flow > net Income

-4407000

Quarters > 2 > cash Flow > depreciation

6319000

Quarters > 2 > cash Flow > change In Working Capital

-18015000

Quarters > 2 > cash Flow > cash From Operations

-13159000

Quarters > 2 > cash Flow > capital Expenditures

1798000

Quarters > 2 > cash Flow > cash From Investing

-3189000

Quarters > 2 > cash Flow > cash From Financing

7147000

Quarters > 2 > cash Flow > net Change In Cash

-9329000

Quarters > 2 > ratios > PE

-0.10787457469463686

Quarters > 2 > ratios > PB

2.9540233496529833

Quarters > 2 > ratios > ROE

-2.371011997632754

Quarters > 2 > ratios > ROA

-1.5440674106126167

Quarters > 2 > ratios > FCF

-14957000

Quarters > 2 > ratios > Piotroski FScore

0

Quarters > 2 > ratios > fcf Percent

-0.2077245708571746

Quarters > 2 > health Score

30

Quarters > 3 > quarter

2024-11-30

Quarters > 3 > income Statement > revenue

72845000

Quarters > 3 > income Statement > cost Of Revenue

32939000

Quarters > 3 > income Statement > gross Profit

39906000

Quarters > 3 > income Statement > operating Expenses

51000000

Quarters > 3 > income Statement > operating Income

-11094000

Quarters > 3 > income Statement > interest Expense

-

Quarters > 3 > income Statement > pretax Income

-10848000

Quarters > 3 > income Statement > net Income

-10738000

Quarters > 3 > income Statement > eps

-0.2624016421484776

Quarters > 3 > income Statement > dividends Per Share

-

Quarters > 3 > income Statement > shares Outstanding

40922000

Quarters > 3 > income Statement > income Tax Expense

-110000

Quarters > 3 > income Statement > EBITDA

1793000

Quarters > 3 > income Statement > operating Margin

-15.22959708971103

Quarters > 3 > income Statement > total Other Income Expense Net

246000

Quarters > 3 > balance Sheet > cash

54089000

Quarters > 3 > balance Sheet > short Term Investments

-

Quarters > 3 > balance Sheet > receivables

43158000

Quarters > 3 > balance Sheet > inventories

65918000

Quarters > 3 > balance Sheet > total Current Assets

175360000

Quarters > 3 > balance Sheet > property Plant Equipment

32977000

Quarters > 3 > balance Sheet > total Assets

291550000

Quarters > 3 > balance Sheet > payables

34746000

Quarters > 3 > balance Sheet > short Term Debt

4960000

Quarters > 3 > balance Sheet > long Term Debt

-

Quarters > 3 > balance Sheet > total Liabilities

104782000

Quarters > 3 > balance Sheet > equity

186768000

Quarters > 3 > cash Flow > net Income

-10738000

Quarters > 3 > cash Flow > depreciation

6863000

Quarters > 3 > cash Flow > change In Working Capital

3259000

Quarters > 3 > cash Flow > cash From Operations

2473000

Quarters > 3 > cash Flow > capital Expenditures

797000

Quarters > 3 > cash Flow > cash From Investing

-1961000

Quarters > 3 > cash Flow > cash From Financing

-1123000

Quarters > 3 > cash Flow > net Change In Cash

-916000

Quarters > 3 > ratios > PE

-0.2624016421484776

Quarters > 3 > ratios > PB

2.9447854022102287

Quarters > 3 > ratios > ROE

-5.749378908592479

Quarters > 3 > ratios > ROA

-3.6830732292917165

Quarters > 3 > ratios > FCF

1676000

Quarters > 3 > ratios > Piotroski FScore

2

Quarters > 3 > ratios > fcf Percent

0.023007756194659893

Quarters > 3 > health Score

32

Valuation > metrics > PE

-0.2648030310390052

Valuation > metrics > PB

3.0940066534343464

Valuation > final Score

49.059933465656535

Valuation > verdict

3.1% Overvalued

Profitability > metrics > ROE

-6.095999552710296

Profitability > metrics > ROA

-6.959835563272393

Profitability > metrics > Net Margin

-0.14400813620213707

Profitability > final Score

0

Profitability > verdict

Weak

Risk > metrics > Debt Equity

0.4852366442089961

Risk > metrics > Interest Coverage

-2664

Risk > final Score

-10596

Risk > verdict

High

Liquidity > metrics > Current Ratio

4.913618969951697

Liquidity > metrics > Quick Ratio

2.960949752211279

Liquidity > final Score

100

Liquidity > verdict

Great

Prev Valuations > 0

49.89534021970815

Prev Valuations > 1

80

Prev Valuations > 2

80

Prev Profitabilities > 0

0

Prev Profitabilities > 1

0

Prev Profitabilities > 2

0

Prev Risks > 0

45

Prev Risks > 1

38

Prev Risks > 2

44

Prev Liquidities > 0

100

Prev Liquidities > 1

100

Prev Liquidities > 2

100

Updated At

2025-12-13T00:25:26.508Z